Cart
sales@molnova.com
Ecliptasaponin D
CAS No. 206756-04-9
Ecliptasaponin D( —— )
Catalog No. M31377 CAS No. 206756-04-9
Ecliptasaponin D is a natural product for research related to life sciences.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 110 | In Stock |
|
| 10MG | 170 | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
Biological Information
-
Product NameEcliptasaponin D
-
NoteResearch use only, not for human use.
-
Brief DescriptionEcliptasaponin D is a natural product for research related to life sciences.
-
DescriptionEcliptasaponin D is a natural product for research related to life sciences.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number206756-04-9
-
Formula Weight634.84
-
Molecular FormulaC36H58O9
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (157.52 mM)
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Fibrinogen-Binding P...
Fibrinogen-Binding Peptide (designed by anticomplementarity hypothesis) is a presumptive peptide mimic of the vitronectin binding site on the fibrinogen receptor.?Fibrinogen-Binding Peptide binds fibrinogen and inhibits both the adhesion of platelets to fibrinogen and platelet aggregation, and also inhibits the adhesion of platelets to vitronectin
-
OTs-C6-OBn
OTs-C6-OBn is an alkyl chain-based PROTAC linker that can be used in the synthesis of PROTAC SGK3 degrader-1.
-
Benin
Benin is an effective cytostatic drug used for the treatment of generalized carcinoma of the breast.
